David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Textron
TXT
$14.3B
| $145M | 0.1% |
1,801,956
-129,430
| -7% | -$9.36M |
|
227
Cardinal Health
CAH
$53.4B
| $144M | 0.1% |
856,279
-413,922
| -33% | -$61.4M |
|
228
Bloom Energy
BE
$59.3B
| $143M | 0.1% |
5,976,583
+2,375,797
| +66% | +$46M |
|
229
CALL
Applovin
APP
$102B
| $143M | 0.1% |
407,900
+14,000
| +4% | +$4.54M |
|
230
CALL
Johnson & Johnson
JNJ
$651B
| $143M | 0.1% |
933,200
+77,600
| +9% | +$11.9M |
|
231
Tenet Healthcare
THC
$22.6B
| $142M | 0.1% |
808,254
+79,990
| +11% | +$12M |
|
232
PepsiCo
PEP
$196B
| $141M | 0.1% |
1,070,983
+453,879
| +74% | +$61.1M |
|
|
SCHW
233
Charles Schwab
SCHW
$194B
| $140M | 0.1% |
1,534,596
-6,383,046
| -81% | -$534M |
|
234
PUT
Chipotle Mexican Grill
CMG
$46.7B
| $140M | 0.1% |
2,486,900
-27,900
| -1% | -$1.42M |
|
235
Enphase Energy
ENPH
$5.1B
| $139M | 0.1% |
3,516,598
+3,362,860
| +2,187% | +$155M |
|
236
Cenovus Energy
CVE
$60.7B
| $138M | 0.1% |
10,163,990
-2,173,626
| -18% | -$28.2M |
|
237
PUT
Dell
DELL
$286B
| $138M | 0.1% |
1,125,800
-34,100
| -3% | -$3.49M |
|
238
PUT
Citigroup
C
$221B
| $138M | 0.1% |
1,619,500
-766,800
| -32% | -$55.4M |
|
239
Norfolk Southern
NSC
$78.8B
| $138M | 0.1% |
+537,686
| New | +$127M |
|
240
PUT
Spotify
SPOT
$110B
| $137M | 0.1% |
179,000
-30,100
| -14% | -$19.3M |
|
241
GE HealthCare
GEHC
$33.8B
| $137M | 0.1% |
1,851,672
+1,839,430
| +15,026% | +$128M |
|
242
Dave Inc
DAVE
$4.52B
| $136M | 0.1% |
506,316
+420,653
| +491% | +$66.3M |
|
243
CALL
Mercado Libre
MELI
$97.5B
| $135M | 0.1% |
51,700
+19,100
| +59% | +$44.6M |
|
244
CNX Resources
CNX
$5.38B
| $135M | 0.1% |
3,998,150
+286,875
| +8% | +$9.04M |
|
245
CrowdStrike
CRWD
$195B
| $134M | 0.1% |
1,052,108
+821,496
| +356% | +$89M |
|
|
VRNA
246
DELISTED
Verona Pharma
VRNA
| $134M | 0.09% |
1,415,219
+801,222
| +130% | +$59.3M |
|
247
CALL
Intel
INTC
$476B
| $134M | 0.09% |
5,967,700
+1,767,700
| +42% | +$36.6M |
|
248
CALL
DoorDash
DASH
$96.8B
| $133M | 0.09% |
540,500
+154,400
| +40% | +$31M |
|
249
PUT
Canadian Imperial Bank of Commerce
CM
$106B
| $133M | 0.09% |
1,874,900
+894,800
| +91% | +$57.6M |
|
250
AstraZeneca
AZN
$257B
| $133M | 0.09% |
952,472
+103,576
| +12% | +$14.5M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.